Cerebral Infarction (Brain Infarction) Global Clinical Trials Review, H1, 2012GlobalDataApril 25, 2012 88 Pages - SKU: GBDT3871793 |
|
China Pharmaceutical Guidebook Series (4) 2013 Edition Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration: A Guidebook of Registration Application for Imported Traditional Chinese Medicines and Natural Medi
5/20/2013 | published by: Access China Management Consulting Ltd.
The traditional medicines in Orient, especially, the traditional Chinese medicines are always regarded by occidental as mysterious medicines. Until today not only the chemical composition of traditional Chinese medicines almost can not been expressed by
|
read more...
|
$750.00
|
|
Global Cardiac Bio Implant Devices (Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Heart Valve, Coronary Stent, Peripheral Stent, Ventricular Assist Device) Market Forecast, Clinical Trials, M&A
5/20/2013 | published by: Renub Research
The cardiac implant medical device market is forecasted to grow in single digit percent per year during 2010-2017 and is likely to exceed US$ 27 Billion by 2017. Growth in this sector is anticipated to
|
read more...
|
$1,600.00
|
|
China Pharmaceutical Guidebook Series (3) 2013 Edition Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration: A Guidebook of Registration Application for Imported Biological Products
5/10/2013 | published by: Access China Management Consulting Ltd.
The biopharmaceutical industry is one of the burgeoning industries. In the field of biopharmaceuticals, vast knowledge awaits people to explore. The biopharmaceuticals are diversified and complex. In China, the development of biopharmaceutical industry is far
|
read more...
|
$750.00
|
|
Alcohol Addiction – Pipeline Review, H1 2013
4/10/2013 | published by: Global Markets Direct
Alcohol Addiction – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Alcohol Addiction - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Alcohol Addiction,
|
read more...
|
$2,000.00
|
|
Mild Cognitive Impairment – Pipeline Review, H1 2013
4/10/2013 | published by: Global Markets Direct
Mild Cognitive Impairment – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Mild Cognitive Impairment - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for
|
read more...
|
$2,000.00
|
|
Brain Cancer Drug Pipeline Update 2013
4/22/2013 | published by: BioSeeker Group AB
Brain Cancer Drug Pipeline Update 2013 Despite the heavy investment made into brain cancer research, primary brain cancer, with glioblastoma multiforme being the most aggressive and most common form, remains one of the most deadly diseases
|
read more...
|
$5,621.25
|
|
Dyslexia Global Clinical Trials Review, H1, 2013
4/12/2013 | published by: GlobalData
Dyslexia Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Dyslexia Global Clinical Trials Review, H1, 2013 provides data on the Dyslexia clinical trial scenario. This report provides elemental information and data relating to the
|
read more...
|
$2,500.00
|
|
Analytical Tool - Cancer Immunotherapy
4/22/2013 | published by: BioSeeker Group AB
Analytical Tool- Cancer Immunotherapy offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in immunotherapy drug development for the treatment of cancer. It is at the same time a
|
read more...
|
$20,437.50
|
|
Tardive Dyskinesia Global Clinical Trials Review, H1, 2013
4/12/2013 | published by: GlobalData
Tardive Dyskinesia Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Tardive Dyskinesia Global Clinical Trials Review, H1, 2013 provides data on the Tardive Dyskinesia clinical trial scenario. This report provides elemental information and data
|
read more...
|
$2,500.00
|
|
Bronchospasm Global Clinical Trials Review, H1, 2013
4/12/2013 | published by: GlobalData
Bronchospasm Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Bronchospasm Global Clinical Trials Review, H1, 2013 provides data on the Bronchospasm clinical trial scenario. This report provides elemental information and data relating to the
|
read more...
|
$2,500.00
|
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
CNS/Neurology Reports